I have to ask though, what do you think prompted Novartis to partner with Mesoblast for all cause ARDS?
Was i just the hype of C19?
Was it the crazy results of the Mt Sanai 10?
Or was it the the fact that Rem - l smashed it with gvhd, scored a BLA with priority and tallied a 9-1 voted with an expert panel?
Whatta ya reckon?
MSB to dispute FDA finding in Type A meeting, page-821
-
- There are more pages in this discussion • 197 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.020(1.34%) |
Mkt cap ! $1.724B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $18.15M | 12.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3418 | $1.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 24361 | 5 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |